ABBV logo

AbbVie (ABBV) Retained Earnings

Annual Retained Earnings

-$1.00 B
-$5.78 B-120.90%

31 December 2023

ABBV Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$4.96 B
-$1.20 B-31.74%

30 September 2024

ABBV Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABBV Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-120.9%-632.0%
3 y3 years-194.8%-410.3%
5 y5 years-129.7%-235.2%

ABBV Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-120.9%at low-197.3%at low
5 y5 years-120.9%at low-183.1%at low
alltimeall time-118.3%at low-173.1%at low

AbbVie Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$4.96 B(+31.7%)
June 2024
-
-$3.77 B(+58.1%)
Mar 2024
-
-$2.38 B(+138.4%)
Dec 2023
-$1.00 B(-120.9%)
-$1.00 B(-207.2%)
Sept 2023
-
$933.00 M(-47.8%)
June 2023
-
$1.79 B(-25.2%)
Mar 2023
-
$2.39 B(-50.0%)
Dec 2022
$4.78 B(+53.0%)
$4.78 B(-3.4%)
Sept 2022
-
$4.95 B(+40.9%)
June 2022
-
$3.52 B(-31.1%)
Mar 2022
-
$5.10 B(+63.2%)
Dec 2021
$3.13 B(+196.4%)
$3.13 B(+95.4%)
Sept 2021
-
$1.60 B(+116.2%)
June 2021
-
$740.00 M(-67.7%)
Mar 2021
-
$2.29 B(+117.3%)
Dec 2020
$1.05 B(-77.6%)
$1.05 B(-68.4%)
Sept 2020
-
$3.33 B(+6.5%)
June 2020
-
$3.13 B(-47.6%)
Mar 2020
-
$5.97 B(+26.6%)
Dec 2019
$4.72 B(+40.1%)
$4.72 B(+28.4%)
Sept 2019
-
$3.67 B(+8.5%)
June 2019
-
$3.38 B(-20.1%)
Mar 2019
-
$4.23 B(+25.7%)
DateAnnualQuarterly
Dec 2018
$3.37 B(-38.3%)
$3.37 B(-50.4%)
Sept 2018
-
$6.79 B(+23.5%)
June 2018
-
$5.50 B(+10.4%)
Mar 2018
-
$4.98 B(-8.8%)
Dec 2017
$5.46 B(+24.7%)
$5.46 B(-16.6%)
Sept 2017
-
$6.55 B(+10.0%)
June 2017
-
$5.95 B(+17.5%)
Mar 2017
-
$5.06 B(+15.6%)
Dec 2016
$4.38 B(+94.8%)
$4.38 B(+9.1%)
Sept 2016
-
$4.01 B(+19.8%)
June 2016
-
$3.35 B(+25.3%)
Mar 2016
-
$2.67 B(+18.9%)
Dec 2015
$2.25 B(+320.2%)
$2.25 B(+35.9%)
Sept 2015
-
$1.65 B(+31.7%)
June 2015
-
$1.26 B(+70.0%)
Mar 2015
-
$739.00 M(+38.1%)
Dec 2014
$535.00 M(-65.9%)
$535.00 M(-74.9%)
Sept 2014
-
$2.13 B(-7.3%)
June 2014
-
$2.30 B(+22.7%)
Mar 2014
-
$1.87 B(+19.6%)
Dec 2013
$1.57 B
$1.57 B(+45.0%)
Sept 2013
-
$1.08 B(+42.6%)
June 2013
-
$758.00 M(+129.7%)
Mar 2013
-
$330.00 M

FAQ

  • What is AbbVie annual retained earnings?
  • What is the all time high annual retained earnings for AbbVie?
  • What is AbbVie annual retained earnings year-on-year change?
  • What is AbbVie quarterly retained earnings?
  • What is the all time high quarterly retained earnings for AbbVie?
  • What is AbbVie quarterly retained earnings year-on-year change?

What is AbbVie annual retained earnings?

The current annual retained earnings of ABBV is -$1.00 B

What is the all time high annual retained earnings for AbbVie?

AbbVie all-time high annual retained earnings is $5.46 B

What is AbbVie annual retained earnings year-on-year change?

Over the past year, ABBV annual retained earnings has changed by -$5.78 B (-120.90%)

What is AbbVie quarterly retained earnings?

The current quarterly retained earnings of ABBV is -$4.96 B

What is the all time high quarterly retained earnings for AbbVie?

AbbVie all-time high quarterly retained earnings is $6.79 B

What is AbbVie quarterly retained earnings year-on-year change?

Over the past year, ABBV quarterly retained earnings has changed by -$5.90 B (-632.05%)